Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Urologic Neoplasms 2Stomach Neoplasms 2Brain Neoplasms 2beta-Thalassemia 1Urinary Bladder Neoplasms 1Supratentorial Brain Tumor Surgery 1Strabismus 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Post-operative Residual Curarization 1Obesity 1Neuromuscular Blockade 1Neoplasms 1Myasthenia Gravis 1Hepatoblastoma 1Endobronchial Metastases 1Emergence Delirium 1Delayed Emergence from Anesthesia 1

Interventions

Exercise 24Metformin 19Tirzepatide 9Resistance Training 8Nutrition Assessment 8Methods 8Diet Therapy 8Diet 8Counseling 7Surveys and Questionnaires 6semaglutide 5Liraglutide 5Exenatide 5Early Intervention, Educational 5Diet, Mediterranean 5Caloric Restriction 5Blood Specimen Collection 5Educational Status 4Bariatric Surgery 4Vitamin D 3Sugars 3Standard of Care 3Naltrexone 3Letrozole 3Docosahexaenoic Acids 3Dexamethasone 3Bupropion 3exemestane 2bupropion hydrochloride, naltrexone hydrochoride drug combination 2Yoga 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Obesity × Sugammadex × Clear all
NCT03196791 2021-07-12

Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient

Korea University Anam Hospital

Phase 3 Completed
196 enrolled 11 charts
GastrointestinalOther

Obesity, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡